[Antimicrobial resistance surveillance: VIRA STUDY 2006]

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Multi-drug resistant (MDR) bacteria pose a significant global health threat.
• Tracking antimicrobial susceptibility patterns is crucial for effective treatment strategies.
• Previous VIRA studies in 2001 and 2004 established baseline resistance data.

Purpose of the Study:

• To determine current antimicrobial susceptibility patterns of frequent MDR bacteria.
• To analyze changes in resistance patterns compared to 2001 and 2004 VIRA studies.
• To inform strategies for combating MDR pathogen emergence and spread.

Main Methods:

• Hospitals collected and submitted key MDR bacterial isolates in February 2006.
• Microorganisms included non-penicillin-susceptible Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus (MRSA), and others.
• Broth microdilution method was used to determine antimicrobial susceptibility.

Main Results:

• Significant decrease in penicillin resistance for Streptococcus pneumoniae (14.3% in 2006).
• Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli was 12.1%.
• Acinetobacter baumannii resistance to imipenem increased significantly from 27% to 47.8% (p < 0.005).

Conclusions:

• Resistance surveillance systems are vital for preventing the emergence and spread of MDR pathogens.
• The study highlights evolving resistance trends requiring adaptive clinical and public health responses.
• Continued monitoring is essential to guide antimicrobial stewardship efforts.